Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2026-02-25 @ 8:48 PM
Study NCT ID:
NCT02116959
Status:
TERMINATED
Last Update Posted:
2020-04-16
First Post:
2014-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-18
First Submit QC Date:
None
Study First Post Date:
2014-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-14
Last Update Post Date:
2020-04-16
Last Update Post Date Type:
ACTUAL